We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy.

list of NY corporations

Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug


The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.
read more

Source: NY Times


23:05, June 10, 2024 Gina Kolata and Pam Belluck

You may also like

News